- Investing Ideas
- /
- U.S. Pharmaceuticals & Biotech Undiscovered Gems With Strong Fundamentals
U.S. Pharmaceuticals & Biotech Undiscovered Gems With Strong Fundamentals
Results
5
High-performing small cap companies that haven't yet garnered significant analyst attention, and could lead to superior returns.
5 companies
China SXT Pharmaceuticals
Market Cap: US$193.8m
A pharmaceutical company, engages in the research, development, manufacture, marketing, and sale of traditional Chinese medicine pieces (TCMP) in China.
SXTC
US$1.69
7D
-1.2%
1Y
-80.8%
Puma Biotechnology
Market Cap: US$170.8m
A biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally.
PBYI
US$3.36
7D
-4.5%
1Y
-9.2%
BioStem Technologies
Market Cap: US$174.9m
A life sciences corporation, focuses on discovering, developing, and producing pharmaceutical and regenerative medicine products and services.
BSEM
US$11.50
7D
-7.6%
1Y
20.4%
Champions Oncology
Market Cap: US$106.9m
A technology-enabled research company, provides transformative technology solutions for drug discovery and development in the United States.
CSBR
US$8.36
7D
-5.1%
1Y
69.9%
SIGA Technologies
Market Cap: US$484.4m
A commercial-stage pharmaceutical company, focuses on the health security market in the United States.
SIGA
US$6.70
7D
-2.9%
1Y
-26.0%